165 related articles for article (PubMed ID: 26697997)
1. Altered neural signaling and immune pathways in peripheral blood mononuclear cells of schizophrenia patients with cognitive impairment: A transcriptome analysis.
Wu JQ; Green MJ; Gardiner EJ; Tooney PA; Scott RJ; Carr VJ; Cairns MJ
Brain Behav Immun; 2016 Mar; 53():194-206. PubMed ID: 26697997
[TBL] [Abstract][Full Text] [Related]
2. Molecular signatures associated with cognitive deficits in schizophrenia: a study of biopsied olfactory neural epithelium.
Horiuchi Y; Kondo MA; Okada K; Takayanagi Y; Tanaka T; Ho T; Varvaris M; Tajinda K; Hiyama H; Ni K; Colantuoni C; Schretlen D; Cascella NG; Pevsner J; Ishizuka K; Sawa A
Transl Psychiatry; 2016 Oct; 6(10):e915. PubMed ID: 27727244
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of mRNA profiles in blood of early-onset schizophrenia.
Xu Y; Yao Shugart Y; Wang G; Cheng Z; Jin C; Zhang K; Wang J; Yu H; Yue W; Zhang F; Zhang D
Sci Rep; 2016 Jan; 6():16767. PubMed ID: 26733343
[TBL] [Abstract][Full Text] [Related]
4. Sex difference in cognitive impairment in drug-free schizophrenia: Association with miR-195 levels.
Huang X; Bao C; Lv Q; Zhao J; Wang Y; Lang X; Li Z; Yi Z
Psychoneuroendocrinology; 2020 Sep; 119():104748. PubMed ID: 32559610
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.
Green MJ; Cairns MJ; Wu J; Dragovic M; Jablensky A; Tooney PA; Scott RJ; Carr VJ;
Mol Psychiatry; 2013 Jul; 18(7):774-80. PubMed ID: 22733126
[TBL] [Abstract][Full Text] [Related]
6. Interactive effects of polygenic risk and cognitive subtype on brain morphology in schizophrenia spectrum and bipolar disorders.
Quidé Y; Watkeys OJ; Girshkin L; Kaur M; Carr VJ; Cairns MJ; Green MJ
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1205-1218. PubMed ID: 35792918
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells.
Gardiner EJ; Cairns MJ; Liu B; Beveridge NJ; Carr V; Kelly B; Scott RJ; Tooney PA
J Psychiatr Res; 2013 Apr; 47(4):425-37. PubMed ID: 23218666
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Expression of Long Non-Coding RNAs in Schizophrenia Patients.
Chen S; Sun X; Niu W; Kong L; He M; Li W; Zhong A; Lu J; Zhang L
Med Sci Monit; 2016 Sep; 22():3340-51. PubMed ID: 27650396
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.
Wu JQ; Saksena MM; Soriano V; Vispo E; Saksena NK
Virol J; 2015 Jan; 12():4. PubMed ID: 25623235
[TBL] [Abstract][Full Text] [Related]
10. Activated Phosphorylated STAT1 Levels as a Biologically Relevant Immune Signal in Schizophrenia.
Sharma RP; Rosen C; Melbourne JK; Feiner B; Chase KA
Neuroimmunomodulation; 2016; 23(4):224-229. PubMed ID: 27820940
[TBL] [Abstract][Full Text] [Related]
11. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.
Bulzacka E; Boyer L; Schürhoff F; Godin O; Berna F; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chéreau-Boudet I; Chesnoy-Servanin G; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Roux P; Yazbek H; Leboyer M; Fond G;
Schizophr Bull; 2016 Sep; 42(5):1290-302. PubMed ID: 27143795
[TBL] [Abstract][Full Text] [Related]
12. Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia.
Ferretjans R; de Campos SM; Ribeiro-Santos R; Guimarães FC; de Oliveira K; Cardoso AC; Araújo MS; Teixeira-Carvalho A; Martins-Filho OA; Teixeira AL; Salgado JV
Schizophr Res; 2014 Jul; 156(2-3):254-60. PubMed ID: 24853061
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis of Transcriptomic Data of Dorsolateral Prefrontal Cortex and of Peripheral Blood Mononuclear Cells Identifies Altered Pathways in Schizophrenia.
Petralia MC; Ciurleo R; Saraceno A; Pennisi M; Basile MS; Fagone P; Bramanti P; Nicoletti F; Cavalli E
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32260267
[TBL] [Abstract][Full Text] [Related]
14. Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia.
Fan HM; Sun XY; Niu W; Zhao L; Zhang QL; Li WS; Zhong AF; Zhang LY; Lu J
J Mol Neurosci; 2015 Jul; 56(3):562-71. PubMed ID: 25665552
[TBL] [Abstract][Full Text] [Related]
15. Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia.
Roussos P; Katsel P; Davis KL; Giakoumaki SG; Lencz T; Malhotra AK; Siever LJ; Bitsios P; Haroutunian V
Neuropsychopharmacology; 2013 Feb; 38(3):533-9. PubMed ID: 23132271
[TBL] [Abstract][Full Text] [Related]
16. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells.
Gardiner E; Beveridge NJ; Wu JQ; Carr V; Scott RJ; Tooney PA; Cairns MJ
Mol Psychiatry; 2012 Jul; 17(8):827-40. PubMed ID: 21727898
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication.
Kumarasinghe N; Beveridge NJ; Gardiner E; Scott RJ; Yasawardene S; Perera A; Mendis J; Suriyakumara K; Schall U; Tooney PA
Int J Neuropsychopharmacol; 2013 Aug; 16(7):1483-503. PubMed ID: 23442539
[TBL] [Abstract][Full Text] [Related]
18. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.
Misiak B; Stańczykiewicz B; Kotowicz K; Rybakowski JK; Samochowiec J; Frydecka D
Schizophr Res; 2018 Feb; 192():16-29. PubMed ID: 28416092
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
[TBL] [Abstract][Full Text] [Related]
20. Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia.
Asevedo E; Rizzo LB; Gadelha A; Mansur RB; Ota VK; Berberian AA; Scarpato BS; Teixeira AL; Bressan RA; Brietzke E
Physiol Behav; 2014 Apr; 129():194-8. PubMed ID: 24576679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
